Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections

BACKGROUND: Although tenofovir diphosphate (TFV-DP) in dried blood spots (DBS) is a predictor of adherence and pre-exposure prophylaxis efficacy, its utility in human immunodeficiency virus (HIV) treatment remains unknown. METHODS: DBS for TFV-DP were collected up to 3 times over 48 weeks in persons...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Main Authors: Castillo-Mancilla, Jose R, Morrow, Mary, Coyle, Ryan P, Coleman, Stacey S, Gardner, Edward M, Zheng, Jia-Hua, Ellison, Lucas, Bushman, Lane R, Kiser, Jennifer J, Mawhinney, Samantha, Anderson, Peter L
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Articles and Commentaries
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451996/
https://ncbi.nlm.nih.gov/pubmed/30137238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy708
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares